Stuart has a portfolio of roles encompassing: Chair and non-executive Director roles for privately owned businesses, trustee and advisory board roles, active angel investing and mentoring for CEO’s and senior executives.
Stuart’s executive career culminated as Group CEO of Bupa, a position he held for 4 years until May 2016. During Stuart’s tenure Bupa was a leading global health and care company with 84,000 employees around the world, principally in the UK, Australia, Spain, Poland, New Zealand and Chile, as well as Saudi Arabia, Hong Kong, India, Thailand and the USA, and had 32m customers in 190 countries. With no shareholders, it reinvested profits to provide more and better healthcare and fulfil its purpose: longer, healthier, happier lives.
Before joining Bupa, Stuart spent 26 years in senior executive leadership positions with Diageo Plc. He was President of Diageo International between 2004-2011, having been President of Key Markets from 2000-2004. Stuart held a number of other senior general management and finance positions with Diageo including roles based in Japan, USA and Hong Kong. He previously held various financial roles with Procter & Gamble in the UK.
Stuart is Chairman of isoshealth, a Non-Executive Director of Radar Software and a Non- Executive Director of Huma Therapeutics Ltd. He is an active angel investor with 24Haymarket and on a direct basis. He is a member of the Trustee Boards of Pancreatic Cancer UK, United World Schools and is a Trustee and Interim Chair of The Hepworth Wakefield. He is also a member of the Advisory Board of 87% Ltd and the Industrial Advisory Board of The Wellcome Centre for Human Genetics. He is a Fellow of the Association of Chartered Certified Accountants (FCCA).
Stuart has been married to Trish for 40 years, has a large extended family and loves music, hiking, skiing, cooking and wine.